ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,792Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 1802

$708K Total Retail Price of All Prescriptions

Rank: 24 out of 1802

423 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 423 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 423 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 11,262 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 640 582 1 2
SIMVASTATIN 476 432 2 1
OMEPRAZOLE 420 364 3 4
PRAVASTATIN SODIUM 388 353 4 19
LISINOPRIL 383 351 5 3
LOSARTAN POTASSIUM 374 343 6 18
AMLODIPINE BESYLATE 341 306 7 6
FUROSEMIDE 341 331 7 5
POTASSIUM CHLORIDE 311 291 9 15
WARFARIN SODIUM 285 260 10 7
METOPROLOL TARTRATE 262 231 11 9
ATENOLOL 241 203 12 12
DOXAZOSIN MESYLATE 219 196 13 62
METOPROLOL SUCCINATE 195 161 14 13
ALLOPURINOL 181 157 15 24
HYDROCODONE-ACETAMINOPHEN 167 149 S3 16 10
METFORMIN HCL 161 155 17 11
NIASPAN 149 116 18 78
PANTOPRAZOLE SODIUM 137 117 19 44
RANITIDINE HCL 123 96 20 30
DIOVAN 118 118 21 57
HYDROCHLOROTHIAZIDE 114 103 22 8
SERTRALINE HCL 113 113 23 20
ATORVASTATIN CALCIUM 112 96 24 14
CRESTOR 105 57 25 31
DONEPEZIL HCL 103 94 26 26
PROPRANOLOL HCL 102 66 27 115
DIGOXIN 101 100 28 45
MIRTAZAPINE 100 99 29 38
ISOSORBIDE MONONITRATE ER 98 98 30 66
CYMBALTA 95 64 31 75
TAMSULOSIN HCL 93 92 32 28
NAMENDA 90 90 33 34
GLIMEPIRIDE 85 75 34 42
PREDNISONE 80 65 35 33
CITALOPRAM HBR 79 66 36 17
METFORMIN HCL ER 79 72 36 46
FAMOTIDINE 78 62 38 84
KLOR-CON M20 76 76 39 86
TRIAMTERENE-HCTZ 74 59 40 49
EXELON 71 71 41 170
BYSTOLIC 70 70 42 120
BENAZEPRIL HCL 65 64 43 61
CARVEDILOL 63 58 44 36
RISPERIDONE 63 50 44 64
FENTANYL 62 60 S2 46 43
CLONIDINE HCL 62 53 46 77
FINASTERIDE 62 62 46 88
ZOLPIDEM TARTRATE 61 59 49 27
VENLAFAXINE HCL ER 61 50 49 73
CLOPIDOGREL 58 55 51 48
SYNTHROID 56 38 52 118
ALENDRONATE SODIUM 55 55 53 21
TRAMADOL HCL 55 49 53 22
VESICARE 53 49 55 150
ONGLYZA 53 41 55 167
DILTIAZEM ER 52 52 57 110
GABAPENTIN 52 39 57 16
NOVOLOG 51 40 59 100
TRAZODONE HCL 51 40 59 39
LEVETIRACETAM 50 24 61 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.